Resmed (RSMDF) Share-based Compensation (2009 - 2026)

Resmed has reported Share-based Compensation for 18 years, with the latest figure at $26.8 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 11.08% year-over-year to $26.8 million; the trailing twelve-month figure through Mar 2026 stood at $101.6 million (up 15.11% YoY), and the FY2025 full-year result was $91.7 million, up 14.31% from the prior year.
• Share-based Compensation for Q1 2026 stood at $26.8 million, down from $28.9 million in the prior quarter.
• The five-year high for Share-based Compensation was $28.9 million in Q4 2025, with the low at $15.9 million in Q1 2022.
• Historically, Share-based Compensation has averaged $20.7 million across 5 years, with a median of $20.2 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation slipped 5.34% — and 2025, when it gained 27.85%.
• Resmed's Share-based Compensation stood at $16.5 million in 2022, then grew by 20.51% to $19.8 million in 2023, then gained by 14.08% to $22.6 million in 2024, then rose by 27.85% to $28.9 million in 2025, then fell by 7.42% to $26.8 million in 2026.
• The last three Share-based Compensation figures came in at $26.8 million (Q1 2026), $28.9 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.